Auxilium On a Roll ...
Health Care: Drugs
Biocryst Pharmaceuticals (BCRX: NASDAQ)
$3.11 0.19 | 6.51%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.92 |
| 52 Week High | 5.95 |
| 52 Week Low | 2.28 |
| Avg. Daily Vol. (Mil) | 0.36 |
| Beta (3 year) | 2.35 |
| Share Related Items | |
| Mkt Cap (Mil) | 143.58 |
| Shares Out (Mil) | 49.17 |
| Float (Mil) | 41.69 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.00 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 1.30 |
| Total Debt / Equity | 1.30 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 5.43 |
| Price/Book | 6.20 |
| Price/Cash Flow | -2.90 |
| Per Share Data | |
| Earnings | -1.10 |
| Sales | 0.54 |
| Book Value | 0.47 |
| Cash Flow | -0.99 |
| Business Summary | |
|---|---|
| BioCryst Pharmaceuticals, Inc., is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. | |
| General Information | |
| 4505 Emperor Boulevard
Suite 200 Durham, NC 27703 |
|
| www.biocryst.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 75 | |
| CEO: Jon P. Stonehouse | |
| Short Interest | |
| Current Month (Mil) | 3.94 |
| Previous Month (Mil) | 3.60 |
| Short Interest Ratio (Days) | 13.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -62.40 |
| Return on Investments | -94.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with BCRX
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- Usertech
- Userrio grande
- UserDebbie0913 Portfolio 1
- UserPART 7 JPMorgan 28th Annual...
- UserSolana Partners
- UserLatest 2009
- ContributorFast Money's 3 Buys & 4...
- User10 shots
- ContributorCramer's Healthcare Stock Buys
Latest BCRX Headlines from TheStreet
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- Biocryst's Gout Drug Fails to Impress 10.05.11 | 11:10 am
- Dendreon's Blowup Spreads Across Biotech 08.04.11 | 10:08 am
- Biotech Stock Mailbag: Vivus 09.24.10 | 07:09 am
- BioCryst Tripped Up by Downgrade 09.23.10 | 04:09 pm
- Savient: Drug Approval or Another Delay? 09.10.10 | 08:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- BioCryst Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 04.28.10 | 06:04 pm
Press Releases for BCRX
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 05.22.12 | 06:05 am
- BioCryst Provides Corporate Update And Reports First Quarter 2012 Financial Results - Business Wire 05.07.12 | 06:05 am
- BioCryst To Report First Quarter 2012 Financial Results On May 7, 2012 - Business Wire 04.25.12 | 06:04 am
- BioCryst To Present At Two Upcoming Investor Conferences - Business Wire 02.23.12 | 06:02 am
- BioCryst Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.16.12 | 06:02 am
- BioCryst Announces Promising Results From Preclinical Studies Of BCX5191 For Hepatitis C - Business Wire 02.15.12 | 06:02 am
- BioCryst To Announce Fourth Quarter And Full Year 2011 Financial Results On February 16, 2012 - Business Wire 02.06.12 | 06:02 am
- Nancy Hutson Appointed To BioCryst’s Board Of Directors - Business Wire 01.19.12 | 06:01 am
- BioCryst Announces Positive Results From Its Ongoing BCX4208 Phase 2B Study In Patients With Gout - Business Wire 01.08.12 | 05:01 pm
- BioCryst Pharmaceuticals Presents New BCX4208 Gout Data At The 2011 ACR/ARHP Annual Scientific Meeting - Business Wire 11.08.11 | 06:11 am
Partner Headlines for BCRX
- Today's Market News To Trade On: 5 Stocks Making News - Seeking Alpha 03.23.12 | 08:03 am
- UPDATE: Bird Flu Found in the Netherlands - Benzinga 03.19.12 | 01:03 pm
- Noteworthy Institutional 5% Ownership Filings Last Week - Seeking Alpha 03.19.12 | 09:03 am
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Biotechs And Their Trials By Fire - Seeking Alpha 11.07.11 | 09:11 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.04.11 | 09:11 am
- BioCryst Pharmaceuticals To Present New Peramivir Data at the 51st Annual ICAAC Meeting - Benzinga 09.17.11 | 06:09 pm
- A Bullish Speculative Options Bet and a Bearish One - Seeking Alpha 06.30.11 | 09:06 am
- 7 Speculative Healthcare Stocks to Rejuvenate Your Portfolio - Seeking Alpha 05.31.11 | 08:05 am
- UPDATE 1-BioCryst says influenza drug lowers virus concentration - Reuters 01.13.11 | 08:01 am
